Justice Department, Drug Enforcement Administration Briefing 2026-06-30

Estimated reading time: 5 minutes

1. Importer of Controlled Substances Application: United States Pharmacopeial Convention

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13164/importer-of-controlled-substances-application-united-states-pharmacopeial-convention

Sub: Justice Department, Drug Enforcement Administration

Content: United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

2. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Patrick Leahy Bulletproof Vest Partnership Program

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13150/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a

Sub: Justice Department

Content: The Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

3. Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Title-National Motor Vehicle Title Information System (NMVTIS)

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13149/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a

Sub: Justice Department

Content: The Office of Justice Programs, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

4. Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13148/importer-of-controlled-substances-application-veterans-pharmaceuticals-inc

Sub: Justice Department, Drug Enforcement Administration

Content: Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

5. Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13147/bulk-manufacturer-of-controlled-substances-application-veranova-lp

Sub: Justice Department, Drug Enforcement Administration

Content: Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

6. Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13145/importer-of-controlled-substances-application-almac-clinical-services-incorp-acsi

Sub: Justice Department, Drug Enforcement Administration

Content: Almac Clinical Services Incorp. (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

7. Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC

Link: https://www.federalregister.gov/documents/2026/06/30/2026-13144/importer-of-controlled-substances-application-catalent-pharma-solutions-llc

Sub: Justice Department, Drug Enforcement Administration

Content: Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.


Legal Disclaimer

This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please contact us. Read our full Legal Disclaimer, which also includes information on translation accuracy.